Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging.
暂无分享,去创建一个
Cuong Nguyen | Adam E Cohen | Graham T Dempsey | Joel M. Kralj | A. Cohen | J. Mcneish | K. Chaudhary | John D McNeish | B. S. Brown | Khuram W Chaudhary | Nicholas Atwater | Barry S Brown | Joel M Kralj | Nicholas Atwater | Cuong Nguyen | G. Dempsey
[1] M. Sanguinetti,et al. A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.
[2] Gary Gintant,et al. Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium. , 2014, American heart journal.
[3] Praveen Shukla,et al. Chemically defined generation of human cardiomyocytes , 2014, Nature Methods.
[4] Robert Passier,et al. Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro--correlation between contraction force and electrophysiology. , 2015, Biomaterials.
[5] Calum A. MacRae,et al. Wnt11 patterns a myocardial electrical gradient via regulation of the L-type Ca2+ channel , 2010, Nature.
[6] P. Lipp,et al. Genetically encoded Ca2+ indicators in cardiac myocytes. , 2014, Circulation research.
[7] Maurizio Recanatini,et al. Safety of Non-Antiarrhythmic Drugs that Prolong the QT Interval or Induce Torsade de Pointes , 2002, Drug safety.
[8] Rene Spijker,et al. Differentiation of Human Embryonic Stem Cells to Cardiomyocytes: Role of Coculture With Visceral Endoderm-Like Cells , 2003, Circulation.
[9] Thomas Weiser,et al. The Electrophysiological Effects of Cardiac Glycosides in Human iPSC-derived Cardiomyocytes and in Guinea Pig Isolated Hearts , 2011, Cellular Physiology and Biochemistry.
[10] F. Guengerich,et al. Mechanisms of drug toxicity and relevance to pharmaceutical development. , 2011, Drug metabolism and pharmacokinetics.
[11] James A Thomson,et al. Human Embryonic Stem Cells Develop Into Multiple Types of Cardiac Myocytes: Action Potential Characterization , 2003, Circulation research.
[12] D. T. Yue,et al. Optical mapping of optogenetically shaped cardiac action potentials , 2014, Scientific Reports.
[13] T. Baird,et al. Preclinical QT safety assessment: cross-species comparisons and human translation from an industry consortium. , 2014, Journal of pharmacological and toxicological methods.
[14] C Antzelevitch,et al. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. , 2000, European heart journal.
[15] N. Hellen,et al. Action potential morphology of human induced pluripotent stem cell-derived cardiomyocytes does not predict cardiac chamber specificity and is dependent on cell density. , 2015, Biophysical journal.
[16] B. Fermini,et al. Comparative gene expression profiling in human-induced pluripotent stem cell--derived cardiocytes and human and cynomolgus heart tissue. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[17] R Lazzara,et al. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. , 1996, Circulation.
[18] Nathaniel Huebsch,et al. Automated Video-Based Analysis of Contractility and Calcium Flux in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Cultured over Different Spatial Scales. , 2015, Tissue engineering. Part C, Methods.
[19] Charles E. Leonard,et al. Cisapride and ventricular arrhythmia. , 2008, British journal of clinical pharmacology.
[20] S. Yamanaka,et al. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. , 2009, Biochemical and biophysical research communications.
[21] A. Bruening-Wright,et al. The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes. , 2010, Journal of pharmacological and toxicological methods.
[22] C. January,et al. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. , 1998, Biophysical journal.
[23] Gary Gintant,et al. ILSI-HESI cardiovascular safety subcommittee initiative: evaluation of three non-clinical models of QT prolongation. , 2006, Journal of pharmacological and toxicological methods.
[24] H. R. Lu,et al. Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines , 2008, British journal of pharmacology.
[25] Harold Bien,et al. Macroscopic optical mapping of excitation in cardiac cell networks with ultra-high spatiotemporal resolution. , 2006, Progress in biophysics and molecular biology.
[26] H. Himmel. Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds. , 2013, Journal of pharmacological and toxicological methods.
[27] Icilio Cavero,et al. Comprehensive in vitro Proarrhythmia Assay, a novel in vitro/in silico paradigm to detect ventricular proarrhythmic liability: a visionary 21st century initiative , 2014, Expert opinion on drug safety.
[28] Robert W. Mills,et al. Rapid Cellular Phenotyping of Human Pluripotent Stem Cell-Derived Cardiomyocytes using a Genetically Encoded Fluorescent Voltage Sensor , 2014, Stem cell reports.
[29] H. Ahammer,et al. Optical multisite monitoring of cell excitation phenomena in isolated cardiomyocytes , 1995, Pflügers Archiv.
[30] S. Nattel,et al. Ranolazine: Ion‐channel‐blocking actions and in vivo electrophysiological effects , 2004, British journal of pharmacology.
[31] International Conference on Harmonisation; guidance on S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals; availability. Notice. , 2005, Federal register.
[32] Dougal Maclaurin,et al. Mechanism of voltage-sensitive fluorescence in a microbial rhodopsin , 2013, Proceedings of the National Academy of Sciences.
[33] Tomoaki Inoue,et al. Electrophysiological characterization of cardiomyocytes derived from human induced pluripotent stem cells. , 2011, Journal of pharmacological sciences.
[34] Samouil L. Farhi,et al. All-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins , 2014, Nature Methods.
[35] Ofer Binah,et al. Human Embryonic and Induced Pluripotent Stem Cell–Derived Cardiomyocytes Exhibit Beat Rate Variability and Power-Law Behavior , 2012, Circulation.
[36] Jonathan A. Bernstein,et al. Using iPS cells to investigate cardiac phenotypes in patients with Timothy Syndrome , 2011, Nature.
[37] J. Shryock,et al. Antagonism by Ranolazine of the Pro-Arrhythmic Effects of Increasing Late INa in Guinea Pig Ventricular Myocytes , 2004, Journal of cardiovascular pharmacology.
[38] I. Judson,et al. HDAC Inhibitors and Cardiac Safety , 2007, Clinical Cancer Research.
[39] A. Camm,et al. The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. , 2000, Cardiovascular research.
[40] A. Bril,et al. Electrophysiological characterization of BRL-32872 in canine Purkinje fiber and ventricular muscle. Effect on early after-depolarizations and repolarization dispersion. , 1999, European journal of pharmacology.
[41] A. Camm,et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. , 2003, Cardiovascular research.
[42] Van V. Brantner,et al. Spending on new drug development1. , 2010, Health economics.
[43] George A. Truskey,et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014, Nature Medicine.
[44] J. Gibson,et al. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents. , 2014, Journal of pharmacological and toxicological methods.
[45] Y. Kuryshev,et al. Pentamidine-Induced Long QT Syndrome and Block of hERG Trafficking , 2005, Journal of Pharmacology and Experimental Therapeutics.
[46] Rachel D. Vanderlaan,et al. Electrophysiological profiling of cardiomyocytes in embryonic bodies derived from human embryonic stem cells: therapeutic implications. , 2003, Circulation research.
[47] Lior Gepstein,et al. In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. , 2009, Stem cells and development.
[48] N. McMahon,et al. Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[49] James A Thomson,et al. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. , 2011, American journal of physiology. Heart and circulatory physiology.
[50] Gregory F. Lewis,et al. High-throughput cardiac safety evaluation and multi-parameter arrhythmia profiling of cardiomyocytes using microelectrode arrays. , 2015, Toxicology and applied pharmacology.
[51] Jun Zhou,et al. Pentamidine reduces hERG expression to prolong the QT interval , 2005, British journal of pharmacology.
[52] G. Salama,et al. Merocyanine 540 as an optical probe of transmembrane electrical activity in the heart , 1976, Science.
[53] Guy Salama,et al. Simultaneous maps of optical action potentials and calcium transients in guinea‐pig hearts: mechanisms underlying concordant alternans , 2000, The Journal of physiology.
[54] Yasunari Kanda,et al. Assessment of testing methods for drug-induced repolarization delay and arrhythmias in an iPS cell-derived cardiomyocyte sheet: multi-site validation study. , 2014, Journal of pharmacological sciences.
[55] Philip Wong,et al. Pharmacoelectrophysiology of viral-free induced pluripotent stem cell-derived human cardiomyocytes. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[56] D. Zipes,et al. New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil. , 1978, The American journal of cardiology.
[57] P. Lipp,et al. Screening Action Potentials: The Power of Light , 2011, Front. Pharmacol..
[58] José Jalife,et al. Optical Imaging of Voltage and Calcium in Cardiac Cells & Tissues , 2012, Circulation research.
[59] James L Stevens,et al. The future of drug safety testing: expanding the view and narrowing the focus. , 2009, Drug discovery today.
[60] Gary Gintant,et al. An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation. , 2011, Pharmacology & therapeutics.
[61] Hung-Fat Tse,et al. Calcium Homeostasis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes , 2011, Stem Cell Reviews and Reports.
[62] D. Walker,et al. Pharmacokinetic/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog , 2001, Xenobiotica; the fate of foreign compounds in biological systems.
[63] K. Summers,et al. Molecular genetics of long QT syndrome. , 2010, Molecular genetics and metabolism.
[64] Stefan R. Pulver,et al. Ultra-sensitive fluorescent proteins for imaging neuronal activity , 2013, Nature.
[65] Ronald A. Li,et al. Functional sarcoplasmic reticulum for calcium-handling of human embryonic stem cell-derived cardiomyocytes: Insights for driven maturation , 2008, Cell Research.
[66] Euan A Ashley,et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. , 2013, Cell stem cell.
[67] Peter Kohl,et al. Simultaneous Voltage and Calcium Mapping of Genetically Purified Human Induced Pluripotent Stem Cell–Derived Cardiac Myocyte Monolayers , 2012, Circulation research.
[68] J. Verducci,et al. MICE Models: Superior to the HERG Model in Predicting Torsade de Pointes , 2013, Scientific Reports.
[69] V. Fast,et al. Microscopic conduction in cultured strands of neonatal rat heart cells measured with voltage-sensitive dyes. , 1993, Circulation research.
[70] J. Cinca,et al. Sarcoplasmic reticulum and L‐type Ca2+ channel activity regulate the beat‐to‐beat stability of calcium handling in human atrial myocytes , 2011, The Journal of physiology.
[71] U. Ravens,et al. Atrial selectivity of antiarrhythmic drugs , 2013, The Journal of physiology.
[72] Liang Guo,et al. Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[73] M. Lazdunski,et al. HERG and KvLQT1/IsK, the cardiac K+ channels involved in long QT syndromes, are targets for calcium channel blockers. , 1998, Molecular pharmacology.
[74] Richard T. Lee,et al. Stem-cell therapy for cardiac disease , 2008, Nature.
[75] Roger Y. Tsien,et al. Optically monitoring voltage in neurons by photo-induced electron transfer through molecular wires , 2012, Proceedings of the National Academy of Sciences.
[76] C. Lawrence,et al. Can optical recordings of membrane potential be used to screen for drug-induced action potential prolongation in single cardiac myocytes? , 2006, Journal of pharmacological and toxicological methods.
[77] Lior Gepstein,et al. Modelling the long QT syndrome with induced pluripotent stem cells , 2011, Nature.
[78] Florian Engert,et al. Simultaneous mapping of membrane voltage and calcium in zebrafish heart in vivo reveals chamber-specific developmental transitions in ionic currents , 2014, Front. Physiol..
[79] J. Paavola,et al. Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. , 2011, Journal of molecular and cellular cardiology.
[80] P Smith,et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.
[81] P. Doevendans,et al. Differentiation of cardiomyocytes in floating embryoid bodies is comparable to fetal cardiomyocytes. , 2000, Journal of molecular and cellular cardiology.
[82] M. Cannell,et al. Imaging Ca2+ Nanosparks in Heart With a New Targeted Biosensor , 2014, Circulation research.
[83] J F Leclercq,et al. Possible mechanisms of the arrhythmias in the long QT syndrome. , 1985, European heart journal.
[84] D. Fisher. Recent insights into the regulation of cardiac Ca2+ flux during perinatal development and in cardiac failure. , 1995, Current opinion in cardiology.